The intelligent Impella: Future perspectives of artificial intelligence in the setting of Impella support.

Journal: ESC heart failure
PMID:

Abstract

AIMS: Artificial intelligence (AI) has emerged as a potential useful tool to support clinical treatment of heart failure, including the setting of mechanical circulatory support (MCS). Modern Impella pumps are equipped with advanced technology (SmartAssist), enabling real-time acquisition and display of data related to both pump performance and the patient's haemodynamic status. These data emerge as an 'ideal' source for data-driven AI applications to predict the clinical course of an ongoing therapeutic protocol. Yet, no evidence of effective application of AI tools in the setting of Impella support is available. On this background, we aimed at identifying possible future applications of AI-based tools in the setting of temporary MCS with an Impella device.

Authors

  • Filippo Consolo
    Università Vita Salute San Raffaele, Milan, Italy.
  • Jacopo D'Andria Ursoleo
    Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Marina Pieri
    Università Vita Salute San Raffaele, Milan, Italy.
  • Pasquale Nardelli
    Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Lorenzo Cianfanelli
    Department of Cardiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Vittorio Pazzanese
    Department of Cardiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Silvia Ajello
    Department of Cardiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Anna Mara Scandroglio
    Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.